Tag: leukemia

September 27, 2018

Biocure CEO: Our CAR-T Biosimilar Technology is Helping Terminal Leukemia Patients Recover

Biocure Technology CEO Dr. Sang Mok Lee believes the products Biocure is developing for the healthcare industry further the company’s...
July 20, 2018

FDA Grants Approval of Agios’ Pharmaceuticals’ TIBSOVO®

Agios Pharmaceuticals (NASDAQ:AGIO) has announced that TIBSOVO was granted approval from the US Food and Drug Administration (FDA) for treatment...
July 15, 2018

5 Top Weekly NASDAQ Biotech Stocks: Arbutus on Top

Adamis Pharmaceutical, Juniper Pharmaceuticals, Anavex Life Sciences, Arbutus BioPharma and Soleno Therapeutics were last week's top gainers on the NASDAQ...
July 3, 2018

4 Top Biotech Stocks on the TSX of Q2 2018

Which biotech stocks on the TSX have performed the best year-to-date? These four companies have risen to the top of...
May 10, 2018

3D Signatures Strengthens Its Intellectual Property With New Patents Issued for Tests in Alzheimer’s Disease, Hodgkin’s Lymphoma and Multiple Myeloma

3D Signatures Inc. (TSXV:DXD,OTCQB:TDSGF), a personalized medicine company with a proprietary software platform (TeloViewTM) based on the three-dimensional analysis of...
May 8, 2018

Cellular Biomedicine Group Reports First Quarter 2018 Financial Results and Highlights Operational Progress

Cellular Biomedicine (NASDAQ:CBMG) a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies for degenerative...
May 3, 2018

New to the Investing News Network

Here at the Investing News Network our mission is twofold; to provide the latest news and quality education by helping...